These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3418390)
1. Reduction of cellular energy requirements. Screening for agents that may protect against CNS ischemia. Zager EL; Ames A J Neurosurg; 1988 Oct; 69(4):568-79. PubMed ID: 3418390 [TBL] [Abstract][Full Text] [Related]
2. Protection against CNS ischemia by temporary interruption of function-related processes of neurons. Ames A; Maynard KI; Kaplan S J Cereb Blood Flow Metab; 1995 May; 15(3):433-9. PubMed ID: 7714001 [TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of hypothermia and its neuroprotective effects on the recovery of metabolic and electrophysiological function in the ischemic retina in vitro. Quiñones-Hinojosa A; Malek JY; Ames A; Ogilvy CS; Maynard KI Neurosurgery; 2003 May; 52(5):1178-86; discussion 1186-7. PubMed ID: 12699563 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotection against ischemia by metabolic inhibition revisited. A comparison of hypothermia, a pharmacologic cocktail and magnesium plus mexiletine. Maynard KI; Quiñones-Hinojosa A; Malek JY Ann N Y Acad Sci; 1999; 890():240-54. PubMed ID: 10668430 [TBL] [Abstract][Full Text] [Related]
5. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. Ames A; Li YY; Heher EC; Kimble CR J Neurosci; 1992 Mar; 12(3):840-53. PubMed ID: 1312136 [TBL] [Abstract][Full Text] [Related]
6. Energy requirements of glutamatergic pathways in rabbit retina. Ames A; Li YY J Neurosci; 1992 Nov; 12(11):4234-42. PubMed ID: 1359032 [TBL] [Abstract][Full Text] [Related]
7. Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia. Maynard KI; Quiñones-Hinojosa A; Ogilvy CS Neuroreport; 1998 Dec; 9(18):4141-4. PubMed ID: 9926863 [TBL] [Abstract][Full Text] [Related]
8. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Ames A Can J Physiol Pharmacol; 1992; 70 Suppl():S158-64. PubMed ID: 1295666 [TBL] [Abstract][Full Text] [Related]
9. Calorie sources and recovery from central nervous system ischemia. Cherian L; Peek K; Robertson CS; Goodman JC; Grossman RG Crit Care Med; 1994 Nov; 22(11):1841-50. PubMed ID: 7956290 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide modulates energy utilization and improves functional recovery from ischemia in the in vitro rabbit retina. Tam D; Tam M; Maynard KI Ann N Y Acad Sci; 2005 Aug; 1053():258-68. PubMed ID: 16179531 [TBL] [Abstract][Full Text] [Related]
11. GABA agonists fail to protect the retina from ischemia-reperfusion injury. Traustason S; Eysteinsson T; Agnarsson BA; Stefánsson E Exp Eye Res; 2009 Mar; 88(3):361-6. PubMed ID: 19101544 [TBL] [Abstract][Full Text] [Related]
12. Effects of diltiazem on glycolysis and oxidative metabolism in the ischemic and ischemic/reperfused heart. Lopaschuk GD; Barr R; Wambolt R J Pharmacol Exp Ther; 1992 Mar; 260(3):1220-8. PubMed ID: 1545389 [TBL] [Abstract][Full Text] [Related]
13. [Effects of sedative agents on metabolic demand]. Kumba C; Van der Linden P Ann Fr Anesth Reanim; 2008; 27(7-8):574-80. PubMed ID: 18614329 [TBL] [Abstract][Full Text] [Related]
14. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. Clark WM; Madden KP; Rothlein R; Zivin JA J Neurosurg; 1991 Oct; 75(4):623-7. PubMed ID: 1885980 [TBL] [Abstract][Full Text] [Related]
15. Contribution of glial metabolism to neuronal damage caused by partial inhibition of energy metabolism in retina. Zeevalk GD; Nicklas WJ Exp Eye Res; 1997 Sep; 65(3):397-405. PubMed ID: 9299176 [TBL] [Abstract][Full Text] [Related]
17. Effects of nonvolatile agents on oxygen demand and energy status in isolated hepatocytes. Becker GL Anesth Analg; 1988 Oct; 67(10):923-8. PubMed ID: 3421495 [TBL] [Abstract][Full Text] [Related]
18. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents]. Sernov LN; Rozonov IuB; Gatsura VV Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176 [TBL] [Abstract][Full Text] [Related]